HHS seeks proposals for Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
Grants
Copyright © Targeted News Service, 2026
Copyright © Targeted News Service, 2026
2026-07-16
Bailey Malota
WASHINGTON, July 16 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, seeks proposals for the Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research, specifically the R33 Clinical Trial Not Allowed initiative. The funding opportunity, with a total estimated funding of $6.6 million, aims to support exploratory research projects that focus on developing and validating innovative technologies for cancer resea . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 16 -- The U.S. Department of Health and Human Services, through the National Institutes of Health, seeks proposals for the Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research, specifically the R33 Clinical Trial Not Allowed initiative. The funding opportunity, with a total estimated funding of $6.6 million, aims to support exploratory research projects that focus on developing and validating innovative technologies for cancer resea . . .
To gain access to full content fill out the form below.
Information Request Form
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
